drugset / Trial / NCT05511246

Venous Ethanol for Ventricular Tachycardia

NCT05511246

Phase 2 Recruiting 156 enrolled The Methodist Hospital Research Institute
RandomizedParallel-groupTriple-blindTreatment

Summary

Comparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequency ablation combined with venous ethanol in patients with ischemic ventricular tachycardia -Venous Ethanol for Left Ventricular Ischemic Ventricular Tachycardia -VELVET clinical trial

Timeline

Start
2023-04-12
Primary completion
2027-12-12
Completion
2028-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Alcohol Other / unclassified Other